In vivo efficacy of the novel aminoglycoside ACHN-490 in murine infection models
about
Strategies to overcome the action of aminoglycoside-modifying enzymes for treating resistant bacterial infectionsClinical management of infections caused by multidrug-resistant EnterobacteriaceaeIn vivo antibacterial activity of MRX-I, a new oxazolidinone.New trends in aminoglycosides use.Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin.Investigational antimicrobial agents of 2013.Pharmacokinetics and safety of single and multiple doses of ACHN-490 injection administered intravenously in healthy subjectsActivity of plazomicin (ACHN-490) against MDR clinical isolates of Klebsiella pneumoniae, Escherichia coli, and Enterobacter spp. from Athens, Greece.Pipeline of Known Chemical Classes of Antibiotics.A review of patents (2011-2015) towards combating resistance to and toxicity of aminoglycosidesNox2-derived oxidative stress results in inefficacy of antibiotics against post-influenza S. aureus pneumonia.PK/PD models in antibacterial development.Experimental gentamicin nephrotoxicity and agents that modify it: a mini-review of recent research.Antibiotics in development targeting protein synthesis.Aminoglycoside therapy in infectious diseases.Investigational drugs in phase I and phase II clincial trials for the treatment of hospital-acquired pneumonia.The antibiotic pipeline for multi-drug resistant gram negative bacteria: what can we expect?Effects of different resistance mechanisms on susceptibility to different classes of antibiotics in Klebsiella pneumoniae strains: a strategic system for the screening and activity testing of new antibiotics.Evaluation of Pharmacokinetic/Pharmacodynamic Model-Based Optimized Combination Regimens against Multidrug-Resistant Pseudomonas aeruginosa in a Murine Thigh Infection Model by Using Humanized Dosing Schemes.
P2860
Q26859978-D367F176-65CD-4F4E-9FFA-F4F5701C561EQ28246841-13D76FAF-41AE-4A75-9404-683C314C5700Q33623042-602AE588-EE3B-4DE7-945C-8F66C2ED4ECEQ33951177-E1927D0D-1D00-46C4-98EA-47C51FC1384FQ34269044-CCA490E6-4E5D-4DF2-8182-D98C14AF8237Q34375204-2AA53C87-B903-4952-BA8A-24C3681E4900Q34632230-1873427E-E9A7-4B7C-9674-7E3FAA408C77Q36107990-2F1FBE74-8152-474B-9C7E-D970131EA3A2Q36683409-B5584112-A069-4C02-A330-B751584B31F8Q36726249-2256E1E7-1A69-4C65-9B43-F225C56DE792Q37197883-E9D023F4-031A-4DBB-BC88-322C5A15084FQ37325658-1BD6703E-DB89-43C8-AAAD-EE69E9E82AA4Q37877781-F141157A-7BA3-495B-895D-4C1AA6049947Q37970724-11BBBDAD-C293-4FD0-AFAC-A2778AA97531Q38112810-E8D71F3F-0843-4426-B99A-A630E4A1E24FQ38783043-4C87D269-4039-4A20-9177-36512E0546DDQ38892589-C269DD1A-27D7-46A0-ADC5-2C38A19780E8Q41993012-3FFEF1B4-8358-4D8E-B8B4-069F8A59C818Q47656109-79871259-0388-48D1-B2CA-F0DE697CAFB7
P2860
In vivo efficacy of the novel aminoglycoside ACHN-490 in murine infection models
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
In vivo efficacy of the novel aminoglycoside ACHN-490 in murine infection models
@en
In vivo efficacy of the novel aminoglycoside ACHN-490 in murine infection models
@nl
type
label
In vivo efficacy of the novel aminoglycoside ACHN-490 in murine infection models
@en
In vivo efficacy of the novel aminoglycoside ACHN-490 in murine infection models
@nl
prefLabel
In vivo efficacy of the novel aminoglycoside ACHN-490 in murine infection models
@en
In vivo efficacy of the novel aminoglycoside ACHN-490 in murine infection models
@nl
P2093
P2860
P356
P1476
In vivo efficacy of the novel aminoglycoside ACHN-490 in murine infection models
@en
P2093
Corwin F Kostrub
James B Aggen
P2860
P304
P356
10.1128/AAC.00862-10
P407
P577
2011-01-31T00:00:00Z